Maxgrow Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 21 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
as on 20-12-2024
- Revenue -20.52%
(FY 2021)
- Profit 11.05%
(FY 2021)
- Ebitda -17.80%
(FY 2021)
- Net Worth 1.50%
(FY 2021)
- Total Assets -13.66%
(FY 2021)
About Maxgrow Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Rupinder Singh, Harjit Kaur, and Jagjot Singh serve as directors at the Company.
- CIN/LLPIN
U51497PB2003PTC026600
- Company No.
026600
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maxgrow Biotech Private Limited offer?
Maxgrow Biotech Private Limited offers a wide range of products and services, including Flavours & Aromatics, Fruit Flavor, Ayurvedic,Herbal Products & Medicine, Ayurvedic,Herbal Drops & Concentrates, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Micronutrient Fertilizers, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Herbal Capsules.
Who are the key members and board of directors at Maxgrow Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupinder Singh  | Managing Director | 08-Dec-2003 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harjit Kaur | Director | 08-Dec-2003 | Current |
| Jagjot Singh | Director | 21-Apr-2021 | Current |
Financial Performance of Maxgrow Biotech.
Maxgrow Biotech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 20.52% decrease. The company also saw a substantial improvement in profitability, with a 11.05% increase in profit. The company's net worth moved up by a moderate rise of 1.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxgrow Biotech?
In 2021, Maxgrow Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Greenfin Ascent Private LimitedActive 6 years 3 monthsRupinder Singh, Harjit Kaur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Aug 2007 | ₹6.00 M | Open |
How Many Employees Work at Maxgrow Biotech?
Maxgrow Biotech has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxgrow Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxgrow Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
